The business landscape is shifting from a battle of "Who has the most employees?" to "Who has the best prompts?"

I am focused on the idea of an AI-Mediated Research Laboratory. Imagine a biotech firm where the "scientists" are actually specialized AI agents capable of simulating millions of molecular interactions every hour. In this scenario, the solo founder is the architect of the research goal, while the agents perform the labor of discovery.
The How:
Instead of building a physical lab with hundreds of researchers, I would utilize cloud-based lab-as-a-service providers. I would feed my AI agents the latest medical journals and proprietary data to design new compounds. These agents would then send the instructions to robotic labs for physical testing.
The Opportunity:
The cost of drug discovery is currently measured in billions of dollars and decades of time. An AI-first approach reduces that cost by several orders of magnitude. If a single person owns the IP for one successful treatment, they aren't just a founder: they are a unicorn.
We are moving toward a world where a billion dollars in value can be generated by a single mind that knows how to speak to the machine. The gatekeepers of the past are becoming obsolete.